Acrospire Investment Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-637
| Closed | -$10K | – | 350 |
|
|
2017
Q2 | $10K | Sell |
637
-800
| -56% | -$12.6K | 0.01% | 1791 |
|
|
2017
Q1 | $25K | Buy |
+1,437
| New | +$25K | 0.02% | 1487 |
|
|
2016
Q4 | – | Sell |
-2,100
| Closed | -$33K | – | 2247 |
|
|
2016
Q3 | $33K | Buy |
+2,100
| New | +$33K | 0.02% | 1293 |
|
|
2016
Q2 | – | Sell |
-1,000
| Closed | -$13K | – | 2057 |
|
|
2016
Q1 | $13K | Buy |
+1,000
| New | +$13K | 0.01% | 1677 |
|